Clinical trial

Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)

NCT00455325

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-09-01

PhasePHASE2

Study timeline

Study start (actual)2004-09-01Date precision: month

Registry last updated2022-05-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metabolic Syndrome Xunresolved

Overweightunresolved

Hypertensionunresolved

Dyslipidemiasunresolved

Prediabetic Stateunresolved

Interventions

Placebo Comparator: First Intervention (3 weeks)DRUG

Active Comparator: Second Intervention (3 weeks)DRUG

Active Comparator: Third Intervention (3 weeks)DRUG

Active Comparator: Fourth Intervention (3 weeks)DRUG

Sponsors & collaborators

Washington University School of Medicinelead sponsor

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Mapped research locations

St LouisMissouri, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00455325 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.